Category : Search result: HIV drugs India


HIV Couple's Hidden Life in Panaji Revealed

Shaina and Rakesh, an HIV-positive couple in Panaji, build a life together with support from NGO Zindagi. Discover their journey of love, secrecy, and resilience against stigma.

Odisha Reports 2,462 HIV Cases in Seven Months

Odisha detects 2,462 HIV-positive cases from April to October through extensive testing. Ganjam reports highest numbers as officials cite unprotected sex among youth as primary cause. Learn about state's response.

Vintage Car Rally for HIV Awareness in Kolkata

Kolkata NGO organizes Legacy on Wheels vintage car drive to raise HIV awareness ahead of 100-bed hospital opening for marginalized children. Join the movement for child healthcare.

Bengaluru HIV Run Sets Record with 440 Children

Bengaluru's Footprints 2025 charity run saw record participation of 440 HIV-positive children, raising awareness and funds ahead of World AIDS Day. The event featured buddy runners and promoted physical activity resilience.

HIV cases drop in Bengaluru, stigma persists

Bengaluru sees fewer HIV patients due to improved treatment, but stigma remains a major hurdle. Non-profits help low-income families access government ART therapy. Read more.

Indian Companies Set for Semaglutide Device Windfall

Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.

India Shaped Global AIDS Response: Expert

Dr. Gilada reveals how India actively shaped the global fight against AIDS, not just participated. Discover India's crucial role in HIV management ahead of World AIDS Day.

Germany Classifies Date Rape Drugs as Weapons

Germany's justice ministry reclassifies date rape drugs as weapons in criminal trials, strengthening prosecution of sexual assault cases. Learn how this legal change protects victims.

Govt Plans Ban on Online Ads for High-Risk Drugs

Indian government proposes sweeping ban on online advertisements for Schedule G, H, H1, and X drugs to combat self-medication and antimicrobial resistance. Read about the new regulatory changes.

Page 1 of 4